According to an article published May 18, 2018 by James Lyons-Weiler titled “Biased Cochrane Report Ignores Flaws in HPV Vaccine Studies, and Studies of HPV Type Replacement,” the Cochrane Group seemingly has lost its once-peer-review-acknowledged objectivity in science reporting!
Dr. Lyons-Weiler is a research scientist who has called Cochrane on the carpet for not exposing the flaws in the design and scope of a CDC HPV vaccine study and a Cochrane review. That 2016 CDC study had specific input from a U.S. CDC scientist, Lauri E. Markowitz, MD, which Lyons-Weiler claims had “fatal flaws that could be interpreted as steps to obfuscate and hide type replacement.”
In June of 2016, Lyons-Weiler authored “High-Risk HPV Type Replacement Follows HPV Vaccination,” which in the opening paragraph states:
The number of studies that show that partial immunization via available HPV (human papillomavirus) vaccines is not only insufficient at reducing overall HPV infection rates; the vaccines actually cause rarer, more lethal types of HPV to sweep in and the net effect could be devastating increases in HPV-related cancers. [….]
The statistics on the types that are said to be known to cause the most cancers are potentially misleading, because there is an inverse relationship between the ability of pathogen to cause disease (morbidity) and death (mortality). If you count numbers of cases, yes, HPV-16 appears to be high-risk. But the low-frequency types may be even HIGHER risk – which would explain why they are low-frequency.
The study from Germany (Fisher et al., 2016)  is definitive, and we have our answer: HPV type replacement is real, and is caused by partial vaccination against an oncogenic virus group…..
In other words, there is competition among HPV virus types in which selective culling would have the effect of selecting for the non-culled types, which may be more dangerous. Needless to say the same effect can be expected with flu vaccination.